The Natural Products Association (NPA), in a recent public filing with the Food and Drug Administration (FDA), encouraged the adoption of standardized equivalent active ingredient controls across OTC sunscreen clinical trials, clarification of “non-diseased” skin, further guidance on submitting Maximum Usage Protocols, and conscious efforts by FDA to reduce the number of animals used in clinical testing submitted to FDA. “Giving consumers access to more safe and effective sunscreen products a...